Carl Atkinson to Immunotherapy, Adoptive
This is a "connection" page, showing publications Carl Atkinson has written about Immunotherapy, Adoptive.
Connection Strength
0.280
-
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells. Eur J Immunol. 2020 09; 50(9):1386-1399.
Score: 0.155
-
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight. 2017 03 09; 2(5):e90772.
Score: 0.124